Lupin’s Foncoo Partnership Beginning Of China Challenge To AZ, Cipla?
Anglo-French CNS Brands Also Acquired
Lupin’s partnership with Shenzhen Foncoo marks the Indian firm's much-awaited entry into China. Will this and more planned alliances make Lupin a worthy respiratory challenger to AstraZeneca, compatriot Cipla and others in a country where chronic respiratory diseases are the second leading cause of death?
